Renee Aguiar-Lucander
CEO
Calliditas Therapeutics
Khatereh Ahmadi
Head of Search and Evaluation Team, European BD&L Hub
MSD
Mehdi Ainouche
Principal
Jeito
Michael Altorfer
CEO
Swiss Biotech Association
Madeleine Armstrong
News Editor
Evaluate
Gwilym Attwell
Principal
Fish & Richardson
Robin Bhattacherjee
CEO
Actimed Therapeutics
Hubert Birner
Managing Partner
TVM Capital
Florian Brand
CEO
ATAI Life Sciences
Samana Brannigan
Head of Health Technologies
Innovate UK
Eduardo Bravo
CEO
EBAC (European Biotech Acquisition Corporation)
Viola Bronsema
CEO
BIO Deutschland
Roel Bulthuis
Managing Director
INKEF Capital
Matt Cardinal
VP Strategy & Program Leadership
Halloran
Dean Chapman
Director (People + Cyber Solutions)
Willis Towers Watson
Paolo Cionini
Chief Commercial Officer
Almirall
Jean-Philippe Combal
CEO
Vivet Therapeutics
Yuehua Cong
Executive Director, Head of Europe
Simcere Pharmaceutical Group
Maria Dahl
COO and Head of Europe
Innovent Bio
John Dawson
CEO
Oxford BioMedica
Lucas de Breed
Founder
August
Ros Deegan
CEO
OMass Therapeutics
Louise Farley
Partner
Deepbridge Capital
Jason Foster
CEO
Ori Biotech
Chris Garabedian
Chairman and CEO
Xontogeny
Andrew Hack
Managing Director
Bain Capital Life Sciences
Alex Hamilton
Partner
Syncona
Deborah Harland
Venture Partner
SROne
Bill Haynes
Head of Novo Nordisk Research Centre Oxford
Novo Nordisk
Olav Hellebo
CEO
ReNeuron
William Hicks
Co-chair Securities & Capital Markets Group
Mintz
Ben Hohn
Principal - Pharmaceuticals & Biotech, Emerging Pharma Lead
ZS Associates
Anne Horgan
Partner
Cambridge Innovation Capital
Sofia Ioannidou
Partner
Andera Partners
Wouter Joustra
General Partner
Forbion
Pierre-Louis Joffrin
CDO
Mogrify
Markus Kalousek
Global Head Search & Evaluation
Novartis
Maya Khurana
Health and Life Sciences Director
Oliver Wyman
Dima Kuzmin
Managing Director
4BIO Capital
Werner Lanthaler
CEO
Evotec
Marta Helena Lesko
Head of BD Enabling Technologies
Merck KGaA
Peter Llewellyn-Davies
CEO
APEIRON
Nicoletta Loggia
CTO
Orchard Therapeutics
Philippe Lopes Fernandes
CBO
Ipsen
Tim Luker
VP Venture Science, Corporate BD
Eli Lilly
Gavin MacGregor
Investment Advisor Public Equity
HBM Partners
Priya Mande
CEO
PsiOxus Therapeutics
Dan Marshall
Director Business Development
MSD
Mark McCarthy
Executive Director, Human Genetics; Senior Fellow
Genentech
Robbie McLaren
Partner and Vice Chair of the Global Life Sciences Practice
Latham & Watkins
Jason Mellad
CEO
Start Codon
Elizabeth Mily
EVP Strategy & BD
Bristol Myers Squibb
Berndt Modig
CEO
Pharvaris
Jukka Muhonen
Global BD & Alliances
Orion Pharma
Matthias Müllenbeck
, SVP, Head Global BD & Alliance Management
Merck KGaA
Karl Nägler
Managing Partner
Wellington Partners
Geraldine O’Keeffe
Partner Public Equities
LSP
Tej Panesar
Investment Director, Life Sciences
British Patient Capital
Rebecca Pope (she/her)
UK Digital & Data Science Innovation Lead
Roche UK
Cody Powers
Principal - Portfolio & Pipeline
ZS Associates
Brad Robling
VP Corporate Business Development
Eli Lilly
Kieran Rooney
VP, Strategic Alliances and Licensing
Amryt Pharma
Christina Rossi
Chief Commercial Officer
Blueprint Medicines
Anya Roy
Head of Seed Investments & Technology
Illumina Accelerator
Ed Saltzman
Executive Chairman
Cello Health BioConsulting
Isabella Schidrich
Senior Managing Director
Nasdaq
Graziano Seghezzi
Managing Partner
Sofinnova
Nigel Sheail
Global Head of M&A and BD&L
Novartis
Tom Shepherd
CEO
Captor Therapeutics
João Siffert
CEO & President
Design Therapeutics
Stephanie Sirota
Partner and CBO
RTW Investments
Ulrica Slåne Bjerke
CIO
Arctic Aurora LifeScience
Sander Slootweg
Managing Partner
Forbion
Laurie Smaldone Alsup
CMO/CSO
NDA Group
Rhoda Steel
Head of Community Impact
Johnson & Johnson UK
Anette Steenberg
CEO
Medicon Valley Alliance
Jacob Sten Petersen
Corporate VP, Head of Stem Cell R&D
Novo Nordisk
Dick Sundh
VP, Head of Australia, Canada & Europe
Kite
Steffen Thirstrup
Advisory Board Director
NDA Group
Diana Torgersen
Senior Associate
Novo Seeds
Erik van den Berg
CEO
AM Pharma
Edward van Wezel
Managing Partner
BGV
Bonnie Van Wilgenburg
Principal
Monograph Capital Partners
Valerie Vanhooren
CEO
ONA Therapeutics
Guillaume Vignon
SVP BD
Beigene
Pnina Weitz
Global Head of VC Business Development & Relationship Management
Lonza
Anna Williamson
Executive Director
Roche Pharma Partnering
Don Xu
Managing Director
Lynx Capital
Alexandra Zemp
Partner
McKinsey
Mai-Britt Zocca
CEO
IO Biotech
.jpeg)
%2c%20Kite%20Pharma.jpeg)
